Albert Labs Chief Medical Officer Dr. Malcom Barratt-Johnson joined Steve Darling from Proactive to share details about the private company with a focus on the emerging field of psychedelic-assisted therapy and research. Dr. Barratt-Johnson talks about the origins of Albert Labs and about their recent news the company has done a reverse takeover of ME Resource Corp.
Albert Labs looking to investigate the use of psychedelics to treat anxiety in cancer patients
